Abstract
Dynamic changes in the expression of estrogen receptors have been shown with the progression of prostate cancer. Studies have shown that in the early stages of prostatic carcinoma, the genes encoding the ESR1 and ESR2 estrogen receptors are silenced, occurring low expression of these receptors in tumors confined on prostate. However, ESR1 reappears with cancer progression and, in the meta…